Increasing unusual put option volume: ASTR BIIB

Go back to Increasing unusual put option volume: ASTR BIIB

Yearly Drug Price Changes by Biogen (BIIB), Gilead (GILD), Regeneron (REGN) and Vertex (VRTX) - Truist

January 3, 2022 5:39 AM EST

Truist analyst Robyn Karnauskas recaps recently announced drug price changes by Biogen (NASDAQ: BIIB), Regeneron (NASDAQ: REGN), Vertex Pharma (NASDAQ: VRTX), and Gilead Sciences (NASDAQ:... More